-
Mashup Score: 4Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches - 1 year(s) ago
Dual antiplatelet therapy (DAPT) is the standard approach to prevent thrombotic events in patients undergoing percutaneous coronary intervention and presenting with chronic or acute coronary syndrome
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Chronic Total Occlusion is Not a Risk Factor for Mortality in Patients With Successful Percutaneous Coronary Intervention: A Cohort Study - 1 year(s) ago
Background Fifteen percent of patients with coronary artery disease undergoing angiography have a chronic total occlusion (CTO). The current study aimed to investigate the long‐term prognosis after…
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Chronic Total Occlusion is Not a Risk Factor for Mortality in Patients With Successful Percutaneous Coronary Intervention: A Cohort Study - 1 year(s) ago
Background Fifteen percent of patients with coronary artery disease undergoing angiography have a chronic total occlusion (CTO). The current study aimed to investigate the long‐term prognosis after…
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: - 1 year(s) ago
Abstract Background Observational studies have reported that mortality rates after ST-segment elevation myocardial infarction (STEMI) have been stable since 2006 to 2010. Objectives The aim of this…
Source: www.jacc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve - 1 year(s) ago
Deferral of coronary revascularization is safe whether guided by instantaneous wave-free ratio (iFR) or by fractional flow reserve (FFR). We aimed to assess long-term outcomes in patients deferred from revascularization based on iFR or FFR in a large real-world population.
Source: www.jscai.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Characteristics and Outcomes of Patients Who Underwent Coronary Atherectomy in Centers With and Without On-Site Cardiac Surgery - 1 year(s) ago
We aimed to describe the clinical characteristics and outcomes of patients who underwent atherectomy at the time of percutaneous coronary intervention in centers with on-site surgical centers (SCs) versus nonsurgical centers (NSCs). Patients treated with coronary atherectomy between January 1, 2006, to December 31, 2019, from the British Cardiovascular Society Intervention (BCIS) registry were included. Primary outcomes were in-hospital all-cause mortality and major adverse cardiovascular and cerebrovascular events.
Source: www.ajconline.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Sex Differences in the Progression and Long-Term Outcomes of Native Mild to Moderate Aortic Stenosis: - 1 year(s) ago
Abstract Background There are limited data on the sex differences in the hemodynamic progression and outcomes of early-stage aortic stenosis (AS). Objectives The authors sought to determine sex dif…
Source: www.jacc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Prospective Associations of Aerobic and Muscle-Strengthening Activity With Mortality - 1 year(s) ago
This cohort study examines the prospective associations of different combinations of moderate aerobic physical activity, vigorous aerobic physical activity, and muscle-strengthening activity with all-cause, cardiovascular, and cancer mortality.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
BACKGROUND: Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. Revascularization with coronary artery bypass graft or percutaneous coron
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 13
The US Food and Drug Administration (FDA) has recently approved colchicine to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization,
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches | Circulation: Cardiovascular Interventions https://t.co/7g0TLCrY1B